SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
76.00
Ask:
78.00
Spread: 2.00 (2.632%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

Trading Update

7 May 2025 07:00

RNS Number : 5740H
Accsys Technologies PLC
07 May 2025
 

AIM: AXS

Euronext Amsterdam: AXS

 

07 May 2025

 

Accsys Technologies PLC

("Accsys", the "Group" or the "Company")

 

Trading Update

Continued progress in delivering FOCUS strategy

 

Accsys, the world's leading supplier of premium, high performance and sustainable wood building materials, today provides an update on full year performance for the year ended 31 March 2025 ("FY25"). All numbers in this announcement are unaudited.

Accsys is pleased to announce a strong performance for FY25 and expects to deliver results for the year in line with previously upgraded market consensus¹. This evidences continued progress in delivering on Phase 1 of its FOCUS strategy.

At the recent Investor Strategy Day, Accsys outlined its FOCUS strategy, which is split into three key phases. In Phase 1 "Transform and Improve" (FY24-27), the Group's focus is on driving sustainable, profitable growth from existing assets, maintaining a lean and efficient cost structure and debt reduction, with a run rate sales volume of 100,000m³ at the end of FY27. Phase 2 "Optimise" (FY28-30) will focus on implementing operational efficiencies to deliver the full capacity of the two plants, with a continuous focus on debt reduction driven by strong free cash flow generation. In Phase 3 "Grow" (FY30+), the Company plans to pursue further growth opportunities supported by a strong balance sheet.

Full year performance:

  

FY25

Unaudited  

FY24

Actual

  

 Change  

  

Revenue

Group 

  

€136.6m 

€136.2m 

 -

Aggregated (Group plus JV)²

€147.4m

€136.2m

+8% 

Sales Volumes m³

Group

  

57,104m3 

56,568m3 

+1% 

Total (Group plus JV)³

  

63,864m3 

56,568m3 

+13% 

 

 

· Strong product demand against a challenging market backdrop, with double digit year-on-year Accoya sales volume growth across all geographic regions - UK&I, Rest of Europe, North America, Rest of World

13% year on year growth in total Accoya sales volumes of 63,864m³

16% year on year growth in North America sales volumes, demonstrating the strong market opportunity for the Accoya USA joint venture, which had a successful operational ramp up

· The Company expects FY25 Adjusted Group EBITDA to be in line with previously upgraded market consensus

· Net debt of €42.6m as at 31 March 2025 represents an increase of €2.4m compared to 30 September 2024. This was driven by planned investment in the USA joint venture, higher inventory levels, ensuring product availability to support strong demand and high levels of customer service, offset by the elimination of non-recourse debt in Tricoya UK Ltd

· Funding in place to support growth prospects:

The Company has signed an 18-month extension to its primary debt facilities with ABN Amro extending the maturity to 30 September 2027

· Tricoya UK Ltd, the Accsys subsidiary company established for the construction and operation of the Hull Tricoya plant, was placed into voluntary liquidation on 17 December 2024

Tariffs

· The Company is continuing to monitor developments with regards to US tariffs. Currently, tariff exemptions are in place for lumber imports into the US and the Company's US manufacturing plant enables Accsys to serve US customers with locally manufactured product

Dr Jelena Arsic van OS commented:

"Since outlining our strategic objectives in January, our focus has firmly shifted to execution-and I'm pleased to report we are delivering. This strong trading update confirms we are firmly on track with Phase I of our FOCUS Strategy, driving sustainable, profitable growth.

Accsys represents a compelling investment case: a de-risked capital expenditure profile, protected intellectual property, and world-class products. With our manufacturing strength in Europe and successful commercialisation of our US plant, we are well positioned to seize a significant global market opportunity. Moreover, we remain a focused industry disrupter with the purpose of 'Changing wood to Change the World'."

The Company's financial results for the year ended 31 March 2025 are expected to be announced on the 24 June 2025.

Notes:

1) Accsys considers market consensus FY25 Adjusted EBITDA to be 10.5 million as at 31 March 2025.

2) Accsys has a 60% shareholding in Accoya USA, a joint venture (JV) with Eastman Chemical Company which commenced operations during H1 FY25. Whilst the JV is equity accounted for financial reporting purposes, the aggregated revenue figure includes 60% of the JV revenue. 

3) Total Sales Volumes include all Group sales and 100% of sales from the JV

4) Adjusted Group EBITDA being earnings before interest, tax, depreciation, amortisation and exceptional items of Accsys plus 60% of the US JV's EBITDA.

 

Ends

Enquiries:

Accsys Investor Relations ir@accsysplc.com

 

Panmure Liberum (London) - Nomad and Broker

Nicholas How (NOMAD), Will King +44 (0) 20 3100 2000

 

ABN Amro (Amsterdam) - Broker

Richard van Etten, Dennis van Helmond +31 (0) 20 344 2000

 

Media: 

 

Camarco (UK) accsys@camarco.co.uk

Ginny Pulbrook, Tom Huddart, Tilly Butcher +44 (0)20 3757 4980

Huijskens Sassen Communications (NL)

Clemens Sassen, Tessa Nelissen +31 (0) 20 68 55 955

 

Notes to editors:

 

Accsys (Accsys Technologies PLC) is disrupting the building materials industry with its high-performance wood products and proprietary technology. Driven by its purpose of "changing wood to change the world", Accsys takes fast-growing, certified sustainable wood and turns it into long lasting, eco-friendly building materials - backed by warranties of up to 50 years. Operating in the rapidly growing global wood construction market, Accsys has an established manufacturing footprint in Europe and North America with active product distribution in more than 25 countries. Accsys is listed on the London Stock Exchange AIM market and on Euronext Amsterdam, under the symbols 'AXS'.

Accsys is a Participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business.

Visit www.accsysplc.com 

 

Accoya® is the global leader for high-performance wood. Created through a proprietary acetylation process developed by Accsys, Accoya delivers superior durability and stability, backed by an industry-leading warranty of up to 50 years. It holds Cradle to Cradle Certified® Gold (Full Scope - V3.1) status for its circular economy benefits. Combining the natural beauty of wood with exceptional performance, Accoya is the preferred choice for windows, doors, cladding, and decking - outperforming hardwoods and manmade materials in durability, stability, and sustainability.

Tricoya® acetylated wood chips redefine panel products, creating next-generation panels that thrive outdoors and in wet environments. Recognised as the biggest leap in wood composites in over 30 years, Tricoya panels combine the strength and versatility of traditional products with unmatched durability and eco-friendliness - backed by a warranty of up to 50 years - expanding design and construction possibilities like never before.

To find out more visit: www.accoya.com

Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. 'Accsys' and 'Accsys Technologies' are trading names of Titan Wood Limited ("TWL"), a wholly-owned subsidiary of Accsys Technologies PLC. Accoya®, Tricoya® and the Trimarque Device are registered trademarks owned by TWL, and may not be used or reproduced without written permission from TWL, or in the case of the Tricoya® registered brand trademark, from Tricoya Technologies Limited, a subsidiary of TWL with exclusive rights to exploit the Tricoya® brand.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSSLFWMEISELI
Date   Source Headline
31st Mar 20087:00 amRNSDirector's Interests
28th Mar 20087:01 amRNSDirector's Interests
25th Mar 20087:01 amRNSFull License Agreement
14th Mar 20087:00 amRNSNotifiable Interest
12th Mar 20083:16 pmRNSHolding(s) in Company
11th Mar 20087:00 amRNSNorwegian Agency Agreement
12th Feb 20087:00 amRNSQuarterly Performance Update
31st Jan 20087:01 amRNSTotal Voting Rights
10th Jan 200812:05 pmRNSAdditional Listing
11th Dec 20077:01 amRNSUAE Rights & Expand Capacity
21st Nov 20077:01 amRNSInterim Results
20th Nov 20077:15 amRNSChina License Agreement
20th Nov 20077:01 amRNSNew Business Relationship
15th Oct 20077:00 amRNSLicense Option Agreement
11th Oct 20074:19 pmRNSDirector/PDMR Shareholding
11th Oct 20072:00 pmRNSDirector/PDMR Shareholding
11th Oct 20077:00 amRNSAppointment of new CEO
28th Sep 20077:00 amRNSTotal Voting Rights
26th Sep 20077:01 amRNSDirector's Interests
18th Sep 20077:02 amRNSEuronext Amsterdam Admission
13th Sep 20072:53 pmRNSSUPPLEMENTARY PROSPECTUS
5th Sep 20077:01 amRNSAdditional Listing
4th Sep 20077:02 amRNSProposed Listing
3rd Sep 20077:01 amRNSChina Option Agreement
20th Aug 20077:00 amRNSLISTING ON EURONEXT AMSTERDAM
17th Aug 20077:00 amRNSNew Appointment
16th Aug 20077:00 amRNSHolding(s) in Company
2nd Aug 20076:05 pmRNSTotal Voting Rights
27th Jul 200710:00 amRNSAdditional Listing
28th Jun 20077:01 amRNSPRELIMINARY RESULTS
25th Jun 20077:02 amRNSAgreement
21st Jun 20074:59 pmRNSHolding(s) in Company
4th Jun 20077:01 amRNSHolding(s) in Company
31st May 20077:01 amRNSTotal Voting Rights
24th May 20072:07 pmRNSHolding(s) in Company
23rd May 20079:14 amRNSAppointment
21st May 200711:49 amRNSCompletion of Subscription
16th May 20077:01 amRNSDirectors Options
15th May 20073:19 pmRNSEGM Statement
30th Apr 20072:13 pmRNSTotal Voting Rights
24th Apr 20077:01 amRNSDirector/Notifiable Interests
11th Apr 20077:01 amRNSPosting of circular
2nd Apr 20077:00 amRNSDirector/PDMR Shareholding
28th Mar 20072:18 pmBUSCelanese Corporation Announces Strategic Partnership with Accsys Technologies for Innovative Use of Acetyl Products
28th Mar 20077:04 amRNSStrategic Partnership
19th Mar 20077:02 amRNSProduction commences
6th Feb 20077:00 amRNSHolding(s) in Company
10th Jan 20077:01 amRNSNew Contract
15th Dec 20064:09 pmRNSTotal Voting Rights
13th Dec 200612:52 pmRNSInterim Results - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.